ValGenesis, Inc. and Rephine have partnered to offer compliance solutions to global pharmaceutical companies seeking to improve quality assurance (QA) throughout their supply chains. Under this collaboration, Rephine will deploy and manage advanced digital validation and manufacturing intelligence software tools developed by ValGenesis to improve QA. The two companies will work together to create an integrated governance approach that will mitigate risk and enhance compliance across the supply chain.
According to Bo Olsen, ValGenesis' SVP of Partners, this collaboration aims to promote standardization and consistency in validation throughout the supply chains of life sciences companies. By leveraging the strengths of both companies, their joint solutions will help organizations meet their compliance obligations, reduce risks, increase efficiency, and lower the cost of ensuring quality.
Adam Sherlock, Rephine's CEO, believes that this partnership is the perfect combination of expertise and technology to provide the best solutions for their clients' business challenges. By leveraging ValGenesis's state-of-the-art solutions and Rephine's extensive experience in validation and qualification processes, they can provide customers with validation best practices while improving their internal processes.
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special
offers from Pharmaceutical Outsourcing – all delivered right to your inbox! Sign up now!